Lucid Diagnostics Inc.
LUCD
$1.21
$0.065.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -134.22% | 83.50% | -133.15% | 6.71% | -12.41% |
| Total Depreciation and Amortization | -0.90% | 0.45% | -0.45% | 3.26% | -6.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.57% | -136.09% | 3,054.25% | -76.70% | 75.50% |
| Change in Net Operating Assets | 2.40% | 47.87% | -242.56% | 786.33% | 92.74% |
| Cash from Operations | -3.26% | 15.37% | -26.28% | 2.99% | 11.38% |
| Capital Expenditure | -12.00% | 73.12% | 64.09% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | -12.00% | 73.12% | 64.09% | 26.00% | -- |
| Total Debt Issued | -- | -100.00% | -98.33% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 64.83% | 9.16% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 64.83% | 6.61% | -14.23% | 19,047.87% | -99.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 175.43% | 104.34% | -63.40% | 175.44% | -7,007.95% |